Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of quetiapine on cannabis users
IRCT20250906067145N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of quetiapine in cannabis use disorder (CUD), sponsored by Kashan University of Medical Sciences. Started Oct 2025; status: completed.
02
Drugs
quetiapine
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on IRCT20250906067145N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250906067145N1.